Diagnostic and therapeutic potential of exosomes in Alzheimer's disease
T Soares Martins, D Trindade, M Vaz… - Journal of …, 2021 - Wiley Online Library
Exosomes are small extracellular vesicles released by almost all cell types in physiological
and pathological conditions. The exosomal potential to unravel disease mechanisms, or to …
and pathological conditions. The exosomal potential to unravel disease mechanisms, or to …
Modifications and trafficking of APP in the pathogenesis of Alzheimer's disease
X Wang, X Zhou, G Li, Y Zhang, Y Wu… - Frontiers in molecular …, 2017 - frontiersin.org
Alzheimer's disease (AD), the most common neurodegenerative disorder, is the leading
cause of dementia. Neuritic plaque, one of the major characteristics of AD neuropathology …
cause of dementia. Neuritic plaque, one of the major characteristics of AD neuropathology …
Impact of cytokines and chemokines on Alzheimer's disease neuropathological hallmarks
C Domingues, O AB da Cruz e Silva… - Current Alzheimer …, 2017 - ingentaconnect.com
Background: Alzheimer's disease (AD) is the most common neurodegenerative disorder,
neuropathologically characterized by aggregates of β-amyloid peptides, which deposit as …
neuropathologically characterized by aggregates of β-amyloid peptides, which deposit as …
Molecular insight into the therapeutic promise of flavonoids against Alzheimer's disease
Alzheimer's disease (AD) is one of the utmost chronic neurodegenerative disorders, which is
characterized from a neuropathological point of view by the aggregates of amyloid beta (Aβ) …
characterized from a neuropathological point of view by the aggregates of amyloid beta (Aβ) …
Regulation of mitochondrial functions by protein phosphorylation and dephosphorylation
The mitochondria are double membrane-bound organelles found in most eukaryotic cells.
They generate most of the cell's energy supply of adenosine triphosphate (ATP). Protein …
They generate most of the cell's energy supply of adenosine triphosphate (ATP). Protein …
Role of post‐translational modifications in Alzheimer's disease
The global burden of Alzheimer's disease (AD) is growing. Valiant efforts to develop clinical
candidates for treatment have continuously met with failure. Currently available palliative …
candidates for treatment have continuously met with failure. Currently available palliative …
Sodium selenate activated Wnt/β-catenin signaling and repressed amyloid-β formation in a triple transgenic mouse model of Alzheimer's disease
Accumulating evidences show that selenium dietary intake is inversely associated with the
mortality of Alzheimer's disease (AD). Sodium selenate has been reported to reduce …
mortality of Alzheimer's disease (AD). Sodium selenate has been reported to reduce …
Pharmacological relevance of CDK inhibitors in Alzheimer's disease
Evidence suggests that cell cycle activation plays a role in the pathophysiology of
neurodegenerative diseases. Alzheimer's disease is a progressive, terminal …
neurodegenerative diseases. Alzheimer's disease is a progressive, terminal …
ABC transporters are key players in Alzheimer's disease
CD Pereira, F Martins, J Wiltfang… - Journal of …, 2017 - journals.sagepub.com
Human ATP-binding cassette (ABC) transporters mediate a critical function in the cell,
namely the transport of molecules across lipid membranes. Associated to their ubiquitous …
namely the transport of molecules across lipid membranes. Associated to their ubiquitous …
Modulation of disordered proteins with a focus on neurodegenerative diseases and other pathologies
Intrinsically disordered proteins (IDPs) do not have rigid 3D structures, showing changes in
their folding depending on the environment or ligands. Intrinsically disordered proteins are …
their folding depending on the environment or ligands. Intrinsically disordered proteins are …